Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas. Perreault S, Geurts M, Mahdi J, Schreck KC, et al. Neuro Oncol 2025 Jul 26:noaf164. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Perreault S, Geurts M, Mahdi J, Schreck KC, et al. Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas. Neuro Oncol 2025 Jul 26:noaf164. doi: 10.1093.
PMID: 40717628